[BRKR] Bruker Corporation

Overview

Type of security: Stock

Sector: Capital Goods

Industry: Biotechnology: Laboratory Analytical Instruments

Market Capitalization: 4.03 B

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 21.53 Change: 0.13 (0.61%)
Ext. hours: Change: 0 (0%)

chart BRKR

Refresh chart

Strongest Trends Summary For BRKR

BRKR is in the medium-term up 32% in 3 months. In the long-term up 183% in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Bruker Corporation, together with its subsidiaries, designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Scientific Instruments, and Energy & Supercon Technologies. The Scientific Instruments segment offers instrumentation and automated solutions based on magnetic resonance, mass spectrometry, gas chromatography, X-ray, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology, and infrared and Raman molecular spectroscopy technologies. This segment serves pharmaceutical, biotechnology, and molecular diagnostic companies; academic institutions, medical schools, and other non-profit organizations; clinical microbiology laboratories; government departments and agencies; nanotechnology, semiconductor, chemical, cement, metals, and petroleum companies; and food, beverage, and agricultural analysis companies and laboratories. The Energy & Supercon Technologies segment

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding162.76 M EPS1.06 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -22.72% Sales Growth - Q/Q-30.41% P/E26.14
P/E To EPS Growth P/S2.32 P/BV5.63 Price/Cash Per Share8.19
Price/Free Cash Flow50.06 ROA3.07% ROE7.61% ROI4.44%
Current Ratio2.41 Quick Ratio1.54 Long Term Debt/Equity0.46 Debt Ratio0.76
Gross Margin42.78% Operating Margin5.75% Net Profit Margin3.13% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.1 M Cash From Investing Activities-5.7 M Cash From Operating Activities27 M Gross Profit160.2 M
Net Profit6.5 M Operating Profit15.2 M Total Assets1.77 B Total Current Assets1.3 B
Total Current Liabilities540.5 M Total Debt354.6 M Total Liabilities1.06 B Total Revenue353.5 M
Technical Data
High 52 week36.13 Low 52 week26.45 Last close35.57 Last change1.4%
RSI66.85 Average true range0.67 Beta1.24 Volume306.96 K
Simple moving average 20 days4.14% Simple moving average 50 days11.36% Simple moving average 200 days11.46%
Performance Data
Performance Week3.19% Performance Month22.11% Performance Quart10.19% Performance Half1.71%
Performance Year0.92% Performance Year-to-date19.48% Volatility daily1.43% Volatility weekly3.2%
Volatility monthly6.57% Volatility yearly22.75% Relative Volume101.22% Average Volume772.55 K
New High New Low

News

2019-03-18 07:00:00 | Bruker Highlights New Systems and Applied Market Solutions at Pittcon

2019-03-14 07:00:00 | Bruker Announces Acquisition of Scientific Software Provider Arxspan

2019-03-13 09:30:01 | Why Is Bruker BRKR Up 1.1% Since Last Earnings Report?

2019-03-12 10:26:39 | See what the IHS Markit Score report has to say about Bruker Corp.

2019-03-12 08:45:12 | Here is Why Growth Investors Should Buy Bruker BRKR Now

2019-03-05 07:51:07 | Bruker Corporation NASDAQ:BRKR: Will The Growth Last?

2019-03-04 11:27:00 | Bruker Announces Progress in Advanced Methods and Software Tools for 4D High-Throughput and Ultra-High Sensitivity Proteomics

2019-03-04 09:10:02 | Top Ranked Growth Stocks to Buy for March 4th

2019-02-26 18:04:11 | Bruker Rides on Robust NANO & CALID Groups, Recent Buyouts

2019-02-25 16:05:00 | Bruker Corporation to Present at Investor Conferences

2019-02-22 09:46:02 | Bruker BRKR Upgraded to Buy: Here's Why

2019-02-20 07:20:00 | New Research: Key Drivers of Growth for DISH Network, Avon Products, Merck & Co., Laredo Petroleum, Health Insurance Innovations, and Bruker — Factors of Influence, Major Initiatives and Sustained Production

2019-02-15 07:00:00 | Bruker Announces Quarterly Dividend

2019-02-13 07:26:39 | Is There Now An Opportunity In Bruker Corporation NASDAQ:BRKR?

2019-02-12 09:09:02 | Bruker BRKR Q4 Earnings In Line, Margin Growth Strong

2019-02-12 03:14:04 | Edited Transcript of BRKR earnings conference call or presentation 11-Feb-19 9:30pm GMT

2019-02-11 22:09:46 | Bruker Corp BRKR Q4 2018 Earnings Conference Call Transcript

2019-02-11 17:20:10 | Bruker BRKR Meets Q4 Earnings Estimates

2019-02-11 16:25:04 | Bruker: 4Q Earnings Snapshot

2019-02-11 16:05:00 | Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results

2019-02-11 14:30:00 | Bruker Corporation to Host Earnings Call

2019-02-11 13:04:00 | Stocks Moving After Hours: Bruker, Molina Health, Gilead, Activision

2019-01-29 08:01:52 | See what the IHS Markit Score report has to say about Bruker Corp.

2019-01-29 07:00:00 | Bruker Launches New High-Speed AFM System for Life Science Microscopy Applications

2019-01-25 07:00:00 | Bruker Announces Date and Time of Fourth Quarter 2018 Earnings Release and Webcast

2019-01-22 08:02:21 | See what the IHS Markit Score report has to say about Bruker Corp.

2019-01-18 13:32:02 | Should You Consider Bruker Corporation NASDAQ:BRKR?

2019-01-15 10:10:03 | Can Bruker BRKR Keep the Earnings Surprise Streak Alive?

2019-01-09 08:02:21 | See what the IHS Markit Score report has to say about Bruker Corp.

2019-01-07 03:50:08 | Zacks.com featured expert Kevin Matras highlights: Crocs, Novanta, Abercrombie & Fitch and Bruker

2019-01-04 08:19:01 | Tap 4 Best-Performing Liquid Bets to Boost Portfolio Returns

2019-01-03 07:35:00 | Investor Expectations to Drive Momentum within L3 Technologies, The Goldman Sachs Group, Genuine Parts, Bruker, Omeros, and Aimmune Therapeutics — Discovering Underlying Factors of Influence

2019-01-02 07:00:00 | Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference

2018-12-26 09:34:02 | Top Ranked Growth Stocks to Buy for December 26th

2018-12-20 18:37:00 | Bruker Comments on Block Trade Transaction

2018-12-18 07:00:00 | Bruker Completes the Acquisition of Alicona Imaging GmbH

2018-12-13 18:28:11 | Bruker Profits from NANO & CALID, New Buyout Holds Promise

2018-12-13 07:00:00 | Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications

2018-12-12 03:34:22 | Here is What Hedge Funds Think About Bruker Corporation BRKR

2018-12-10 07:00:00 | Bruker Introduces Advanced Illumination for Next-Generation Lattice Light-Sheet Microscopy

2018-11-15 09:19:14 | Is Bruker Corporation’s NASDAQ:BRKR CEO Salary Justified?

2018-11-14 03:00:00 | Bruker Announces Agreement for the Acquisition of Alicona Imaging GmbH

2018-11-09 08:04:22 | See what the IHS Markit Score report has to say about Bruker Corp.

2018-11-09 07:00:00 | Bruker Announces Quarterly Dividend

2018-11-06 08:50:00 | Analysis: Positioning to Benefit within Bruker, Kite Realty Group Trust, LifePoint Health, Aptiv, AMERISAFE, and NCR — Research Highlights Growth, Revenue, and Consolidated Results

2018-11-05 07:00:00 | Bruker Introduces Next-Generation Wide-Field, Multiphoton Microscope for Optogenetics

2018-11-05 07:00:00 | Bruker Introduces Light-Sheet Microscope for Imaging Optically Cleared Samples

2018-11-02 14:03:06 | Bruker BRKR Q3 Earnings Surpass Estimates, Guidance Up

2018-11-02 08:04:18 | See what the IHS Markit Score report has to say about Bruker Corp.

2018-11-01 22:20:46 | Edited Transcript of BRKR earnings conference call or presentation 1-Nov-18 8:30pm GMT